URGENT: Monteverde & Associates PC is Investigating the Following Transaction

PRNewswire 9-Aug-2019 8:00 PM

NEW YORK, Aug. 9, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

• Genomic Health, Inc. (GHDX) ("Genomic") related to its sale to Exact Sciences Corporation ("Exact Sciences"). Under the terms of the transaction, each share of Genomic common stock will be converted into the right to receive $27.50 in cash and $44.50 in shares of Exact Sciences for each share of Genomic common stock owned. Click here for more information: https://www.monteverdelaw.com/case/genomic-health-inc.  It is free and there is no cost or obligation to you
• Navigant Consulting, Inc. (NCI) ("Navigant") related to its merger with Guidehouse LLP, an affiliate of Veritas Capital. Under the terms of the agreement, each share of Navigant common stock will be converted into the right to receive $28.00 in cash for each share of Navigant common stock owned. Click here for more information: https://www.monteverdelaw.com/case/navigant-consulting-inc.  It is free and there is no cost or obligation to you.
• Gannet Company, Inc. (GCI) ("Gannet") related to its sale to New Media Investment Group Inc. ("New Media"). Under the terms of the proposed transaction, each share of Gannet common stock will be converted into the right to receive $6.25 in cash and 0.5427 shares of New Media common stock per Gannet common stock owned. Click here for more information: https://www.monteverdelaw.com/case/gannet-company-inc.  It is free and there is no cost or obligation to you.
• Cambrex Corporation (CBM) ("Cambrex") related to the sale of the company to an affiliate of the private equity firm Permira Funds. Under the terms of the proposed agreement, each share of Cambrex common stock will be converted into the right to receive $60.00 in cash for each share of Cambrex common stock owned. Click here for more information: https://www.monteverdelaw.com/case/cambrex-corporation.  It is free and there is no cost or obligation to you.
• Avedro, Inc. (AVDR) ("Avedro") regarding its acquisition by Glaukos Corporation ("Glaukos"). Under the terms of the deal, each share of Avedro common stock will be converted into the right to receive 0.365 shares of Glaukos common stock for each share of Avedro common stock owned. Click here for more information: https://www.monteverdelaw.com/case/avedro-inc.  It is free and there is no cost or obligation to you.
• Vitamin Shoppe, Inc. (VSI) ("Vitamin") related to its acquisition by Liberty Tax, Inc.  Under the terms of the proposed transaction, each share of Vitamin common stock will be converted into the right to receive $6.50 in cash per share.  Click here for more information: https://www.monteverdelaw.com/case/vitamin-shoppe-inc.  It is free and there is no cost or obligation to you.
• Corindus Vascular Robotics, Inc. (CVRS) ("Corindus") regarding its merger with Siemens Medical Solutions USA, Inc.  Under the terms of the agreement, each share of Corindus common stock will be converted into the right to receive $4.28 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/corindus-vascular-robotics-inc.  It is free and there is no cost or obligation to you.
• Wesco Aircraft Holdings, Inc. (WAIR) ("Wesco") regarding its acquisition by indirect subsidiaries of funds managed and advised by Platinum Equity Advisors, LLC. Under the terms of the transaction, each share of Wesco common stock will be converted into the right to receive $11.05 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/wesco-aircraft-holdings-inc.  It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

If you own common stock in any of the above companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com 
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC.  The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

View original content to download multimedia:http://www.prnewswire.com/news-releases/urgent-monteverde--associates-pc-is-investigating-the-following-transaction-300899610.html

SOURCE Monteverde & Associates PC